Cargando…
Efficacy and safety of a triple active sore throat lozenge in the treatment of patients with acute pharyngitis: Results of a multi‐centre, randomised, placebo‐controlled, double‐blind, parallel‐group trial (DoriPha)
OBJECTIVE: The aim of this multi‐centre, randomised, double‐blind, placebo‐controlled trial was to compare the efficacy and safety of the fixed combination of 0.5 mg tyrothricin, 1.0 mg benzalkonium chloride, and 1.5 mg benzocaine (study drug marketed as Dorithricin(®)) in repeat dosing for 3 days t...
Autores principales: | Palm, Jürgen, Fuchs, Katharina, Stammer, Holger, Schumacher‐Stimpfl, Anne, Milde, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282512/ https://www.ncbi.nlm.nih.gov/pubmed/30329199 http://dx.doi.org/10.1111/ijcp.13272 |
Ejemplares similares
-
Not All Sore Throats Are Pharyngitis
por: Sadowski, Adam, et al.
Publicado: (2017) -
Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat
por: Matthews, Derek, et al.
Publicado: (2020) -
Pharyngitis and Pharyngeal Space Infections: fever, sore throat, difficulty swallowing
por: Orzell, Susannah, et al.
Publicado: (2018) -
Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
por: Morokutti-Kurz, Martina, et al.
Publicado: (2017) -
Virucidal action of sore throat lozenges against respiratory viruses parainfluenza type 3 and cytomegalovirus
por: Shephard, Adrian, et al.
Publicado: (2015)